American Society of Nephrology
Mark David Lim, Ph.D. PMP, currently serves as Vice President of Research, Discovery, and Innovation at the American Society of Nephrology, where the focus is on enhancing biomedical research for kidney disease improvement. Lim has extensive experience in scientific advisory roles, including a position as a voting member of the Scientific Advisory Committee at CQDM and served on the WHO Roster of Experts in Digital Health. Previous leadership roles include directing global public health programs at the American Society for Microbiology and multiple positions at the Bill & Melinda Gates Foundation, including Program Officer for Diagnostics. Lim's career also includes significant contributions to organizations such as FasterCures, the National Cancer Institute, and Strategic Analysis Incorporated, demonstrating a commitment to advancing biomedical capabilities and public health initiatives through a robust academic background in chemistry and pharmaceutical research.
This person is not in any teams
This person is not in any offices
American Society of Nephrology
1 followers
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge and advocating for the highest quality care for patients. ASN has nearly 22,000 members representing 141 countries. Whether providing expert care to patients, performing cutting-edge medical research, or training the next generation of kidney experts, these nephrologists change lives. ASN funds research, convenes world-renowned meetings and generates educational tools that enable nephrologists to be most effective. Through advocacy, ASN informs policymakers about issues of importance to kidney doctors and their patients. Building on a 50-year history, ASN brings rigor, integrity, and ingenuity to all its work. ASN (Federal Tax ID: 52-6078378) is a 501(c)(3) non-profit, tax-exempt organization.